While the reduction in price target from $88 to $80 could suggest a tempered outlook on Incyte's future stock performance, the maintenance of a Buy rating indicates continued confidence in the company's fundamentals. This mixed signal might lead to short-term uncertainty among investors, potentially stabilizing the stock price as the market digests the implications.